Compositions and methods for decreasing sebum production
AssigneePfizer Inc.
InventorJames T. Mayne
Life of this patent
Estimating the term…
Abstract
A method of treating diseases caused by sebaceous gland disorders, in humans and animals, which comprises administering to said humans and animals a composition comprising a sebaceous gland secretion inhibiting amount of an active compound comprising an acyl coA cholesterol acyl transferase (ACAT) inhibitor or prodrug therefor. A composition for use in treating diseases caused by sebaceous gland disorders such as acne in humans and animals which comprises a sebaceous gland secretion inhibiting amount of an acyl coA cholesterol acyl tanferase (ACAT) inhibitor or prodrug therefor and, optionally, a pharmaceutically acceptable carrier.
Claims21
A method of treating a sebaceous gland disorder in a human or animal in need of said treatment, which comprises administering to said human or animal a composition comprising a sebaceous gland secretion inhibiting amount of an acyl coA cholesterol acyl transferase (ACAT) inhibitor or prodrug therefor.
A composition for use in the treatment of diseases caused by sebaceous gland secretions in humans and animals comprising a sebaceous gland secretion inhibiting amount of an active compound comprising an ACAT inhibitor or prodrug therefor and a tropical carrier.
A method of decreasing sebum production in a human or animal in need of such treatment, which comprises administering to said human or animal a composition comprising a sebum production-inhibiting amount of an acyl coA cholesterol acyl transferase (ACAT) inhibitor or prodrug thereof.
Dependencies are inferred from the claim text.